Cortisol is known to be an immunomodulatory hormone that exerts suppressive
and permissive effects on the immune response. Little is known regarding t
he evolution of the cytokine response in human septic shock in the presence
of hypercortisolemia induced by infusion of stress doses of hydrocortisone
. Twenty-four consecutive patients with high-output circulatory failure (ca
rdiac index, >4 liters/min per m(2)) who met the American College of Chest
Physicians/Society of Critical Care Medicine Consensus Conference Committee
criteria for septic shock were enrolled in a prospective, double-blind stu
dy. The severity of illness at the time of enrollment was graded using the
Acute Physiology and Chronic Health Evaluation II system, and the evolution
of sepsis-induced organ dysfunction syndrome was assessed using Sepsis-Rel
ated Organ Failure Assessment scores. After randomization, hyper cortisolem
ia was induced in 12 patients by infusion of 100 mg of hydrocortisone, foll
owed by continuous infusion of 0.18 mg/kg per h. Levels of the circulating
cytokines tumor necrosis factor alpha (TNF), interleukin 6 (IL-6), IL-8, an
d IL-10 were serially measured at prospectively defined time points during
the first 5 d after randomization. The infusion of hydrocortisone was assoc
iated with significant reductions in serum IL-6 and IL-8 levels and with ea
rlier resolution of the sepsis-induced organ dysfunction syndrome. IL-6 lev
els started to differ between the groups on day 5. The TNF and IL-10 respon
ses were not altered by hydrocortisone infusion. Hydrocortisone infusion in
septic shock differentially regulated the cytokine responses. IL-6 and IL-
8 levels decreased significantly and IL-6 levels differed between the group
s, whereas TNF and IL-10 levels were not affected by hydrocortisone. Stress
doses of hydrocortisone may be a valuable immunomodulatory therapy for sep
tic shock.